Liver Transplantation
Treatment for Liver Cancer Due To Nash
Effectiveness
95%
Safety Score
25%
Clinical Trials
5,000
Participants
200K
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
25
DangerousModerateSafe
Treatment Details
Time to Effect
immediate
Treatment Duration
lifetime
Evidence Quality
HIGHNumber Needed to Treat (NNT)
3(Treat 3 patients to see 1 additional successful outcome)
Number Needed to Harm (NNH)
8(Treat 8 patients to see 1 additional serious adverse event)
Confidence Score
92%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$15,000
Monitoring:$10,000
Side Effect Mgmt:$15,000
Total Annual:$40,000
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
MODERATEICER
$100,000/QALY
QALYs Gained
7
Outcome-Based Costs
Cost per Responder
$40,000
Cost per Remission
$53,333
Comparison vs Hepatic Resection
Cost Difference
+$500,000/year
More expensive
QALY Difference
+2.00 QALYs
Better outcomes
Dominance
No dominance
Liver Transplantation Outcomes
for Liver Cancer Due To Nash
Efficacy Outcomes
Overall Effectiveness
+95%
Response Rate
+100%
Remission Rate
+75%
Common Side Effects
Surgical complications (bleeding, infection)
+15%
Acute rejection
+18%
Chronic kidney disease (due to immunosuppressants)
+20%
Infections (opportunistic)
+40%
Recurrence of HCC
+15%
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov